SCHEMBL2118531

SCHEMBL2118531

Cc1ccc(-c2cccnc2)cc1NS(=O)(=O)c1ccc(Cl)cc1

nearest known ligand 0.61

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
NAMPT P43490 2/20 0.55
ALDH1A1 P00352 1/20 0.54
POLB P06746 2/20 0.52
CCR9 P51686 1/20 0.52
TP53 P04637 1/20 0.52
MAPT P10636 1/20 0.52
SMN1; SMN2 Q16637 1/20 0.52
ABCB1 P08183 1/20 0.51
ABCC1 P33527 1/20 0.51
ACLY P53396 1/20 0.50
PIK3CA P42336 2/20 0.48
MTOR P42345 2/20 0.48
PIK3CD O00329 1/20 0.48
PIK3CB P42338 1/20 0.48
PIK3CG P48736 1/20 0.48
PIK3C3 Q8NEB9 1/20 0.48
HTR6 P50406 2/20 0.48
DRD2 P14416 1/20 0.48
HTR2A P28223 1/20 0.48
HTR2C P28335 1/20 0.48

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL2120534 0.88 ABCB1 (0.51) NAMPTPOLBSMN1; SMN2ABCB1ABCC1
SCHEMBL2118244 0.88 ABCB1 (0.51) NAMPTPOLBSMN1; SMN2ABCB1ABCC1
SCHEMBL2118369 0.85 ALDH1A1 (0.56) ALDH1A1POLBCCR9TP53MAPT
SCHEMBL2117690 0.85 ABCB1 (0.61) NAMPTALDH1A1POLBSMN1; SMN2ABCB1
SCHEMBL2121370 0.83 ALDH1A1 (0.59) ALDH1A1POLBTP53MAPTSMN1; SMN2
SCHEMBL2119981 0.81 ALDH1A1 (0.60) ALDH1A1POLBTP53MAPTSMN1; SMN2
SCHEMBL2118452 0.80 TP53 (0.48) ALDH1A1POLBCCR9TP53MAPT
SCHEMBL2119235 0.79 ABCB1 (0.71) ALDH1A1MAPTABCB1ABCC1ACLY
SCHEMBL2120580 0.79 ALDH1A1 (0.58) ALDH1A1POLBTP53MAPTSMN1; SMN2
SCHEMBL2118685 0.79 POLB (0.57) ALDH1A1POLBCCR9TP53MAPT

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20120095024-A1 TOLUIDINE SULFONAMIDES AND THEIR USE ELARA PHARMACEUTICALS GMBH (DE) 2012-04-19 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20120095024-A1 TOLUIDINE SULFONAMIDES AND THEIR USE HIF1AN, HIF1A, EGLN2 NAMPT 2122/4885ALDH1A1 567/4885POLB 817/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.